Nucleosides, nucleotides and nucleic acids p. 623 - 627 (2003)
Update date:2022-08-04
Topics:
Boesen, Thomas
Pedersen, Daniel Sejer
Jensen, Jacob
Munck, Michael T.
Nielsen, Brian M.
Petersen, Asger B.
Henriksen, Ulla
Dahl, Britta M.
Dahl, Otto
Preparation of the nucleoside analogues 1 and incorporation of 1, B = T, in deoxyribooligonucleotides by the phosphoramidite method is described. A two-step deprotection procedure was developed to reduce cleavage of the modified allylic unit. The binding properties of the modified oligonucleotides towards complementary DNA and RNA has been evaluated by Tm measurements showing a ΔATm of -2 to -6.5°C per modification. An oligonucleotide with two modifications at the 3′-end showed considerable resistance towards cleavage by a 3′-exonuclease. No antiviral activity against HIV-1 or HSV-1 was found for 1, B = G or T, or for any of the trihydroxy derivatives 5.
View MoreJinan Baozhao Pharmaceutical Co., Ltd
Contact:0086-531-86397156 82371858 82371868
Address:Huaneng Road, Jinan, Shandong ,China
Xiamen XM-Innovation Chemical Co., Ltd
Contact:+86-592-3216205
Address:Unit Q, 11/F, No.1 Office Building, Wuyuan Bay Business Center, Huli District, Xiamen City, Fujian Province, P.R.C
Chemsigma International Co.,Ltd.
website:http://www.chemsigma.com
Contact:86-025-58748998
Address:Rm.705, 15th Building,Rd.Xinke II
Jiacheng-Chem Enterprises Limited(expird)
Contact:86-571-86711508
Address:19 Floor, CIBC Holley International Building, No. 198,Wuxing Road, Hangzhou, China,310020
Beijing Tianjia Chemical Science & Technology Co.,Ltd
Contact:86-0550-2392698
Address:No.388, Shiliang Road (East),
Doi:10.1039/b207854f
(2003)Doi:10.1055/s-2003-37517
(2003)Doi:10.1016/j.tetlet.2007.02.096
(2007)Doi:10.1021/acs.joc.0c01703
(2020)Doi:10.1246/bcsj.48.73
(1975)Doi:10.1016/S0040-4020(01)97445-9
(1974)